KALA BIO (KALA) investor relations material

Opening remarks and agenda

• Meeting called to order with confirmation of quorum and agenda overview provided.

• Stockholders informed of procedures for submitting questions and voting.

• Notice of meeting and proxy materials distributed on December 30, 2025.

• Seven agenda items outlined for consideration, with voting instructions given.

Shareholder proposals

• Election of three Class II directors to serve until the 2028 annual meeting.

• Advisory vote on executive compensation as disclosed in the proxy statement.

• Ratification of HCL International LLC as independent auditor for fiscal year ending December 31, 2025.

• Authorization for issuance of common stock upon conversion of Series AA and AAA preferred stock.

• Amendment to increase authorized common stock from 125 million to 1.5 billion shares.

• Authorization for a reverse stock split at a ratio between 1-for-2 and 1-for-100 at board discretion.

• Approval for potential adjournment or postponement of the meeting if needed.

Overview of voting outcomes

• All director nominees elected by plurality of votes cast.

• All proposals, including compensation, auditor ratification, stock issuance, share increase, and reverse split, passed by majority vote.

• Adjournment proposal not required as all other items passed.